Deepali Suri, President of ICON Biotech, has been published in Pharmaceutical Executive. Her article draws on insights from 163 biotech leaders across North America, EMEA and APAC, supported by a supplementary survey o...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
LEO Pharma and ICON partner for clinical trial execution in dermatology
This news article, published on Clinical Trials Arena, outlines how the collaboration is expected to provide access to innovative clinical trials as well as help to launch new medicines.
-
LEO Pharma and ICON enter strategic partnership
This news article, first published on Applied Clinical Trials, outlines that LEO Pharma and ICON have announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective.
-
ICON and LEO Pharma join forces on clinical trial mission
This news article, published on PharmaTimes online, indicates how the collaboration will concentrate on launching and running studies within medical dermatology.
-
LEO Pharma, ICON partner to advance clinical trials in dermatology
This news article, first published on Contract Pharma, covers the strategic partnership between LEO Pharma and ICON to propel clinical trial execution within medical dermatology.
-
The power of partnership: Collaborating with patient advocacy organisations for better clinical research
Laura Iliescu explores the powerful potential of collaboration with PAOs for clinical trials, particularly how PAOs can inform trial design and the creation of patient registries.
-
The evolving relationship between sponsors and contract research organisations
If the last few years have taught us anything, it’s that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together in a truly collaborative way. The opportunity for the clinical development industry is to take what we have learned about how we can work together and use this to continue to drive progress. To strategically support clients, at ICON, this means partnering with sponsors in a way that goes beyond a traditional CRO. It means being a trusted partner.
In this podcast and article Jeff James, EVP Alliance Management, offers his perspective on what it takes to be a trusted partner to sponsors in the clinical development industry. -
Redefining CRO sourcing model terminology to optimise outsourcing strategies
Samir Shah, President, Strategic Solutions at ICON contributes to this Applied Clinical Trials article discussing the compelling need for new terminology for sourcing models in the CRO industry.
Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication of MultiMedia Healthcare, LLC. All rights reserved.
-
How this top CEO helped Pfizer turbocharge the covid-19 vaccine
Steve Cutler discusses ICON's covid-19 efforts, the importance of building a good team, and more in this interview with Investor's Business Daily.
-
Will big tech dominate healthcare in the years ahead?
Louisa Roberts, VP of Corporate Development and Partnerships, considers the benefits of partnerships with tech companies.
-
How CRO venture capital relationships can help biotech fundraising
This article considers how partnering with a CRO can help emerging biotechs to secure funding.
